Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,628
Recruiting: 1,398
Ph III recruiting: 152
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 151–200 of 265 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05095207	Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer	recruiting	Phase 1 / Phase 2	42	Icahn School of Medicine at Mount SinaiOTHER	1	Apr 13, 2026	clinicaltrials
NCT07164976	Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer	recruiting	Phase 1 / Phase 2	86	Nagoya City UniversityOTHER	1	Apr 13, 2026	clinicaltrials